Newronika

Newronika is a leader in advanced deep brain stimulation, developing an adaptive DBS platform designed to provide precision therapy to improve symptom relief and reduce side effects for patients with Parkinson's disease. The company aims to transform neuromodulation by integrating real-time neuronal data and machine learning into its DBS systems.

Funding Round: Series B

Funding Amount: €13.6M

Date: 13-Feb-2025

Investors: Fondazione ENEA Tech e Biomedical, Indaco Venture Partners SGR, Innogest SGR, Wille Finance, TNBT Capital, F3F

Markets: MedTech, Neurotechnology, Healthtech

HQ: Milan, Italy

Founded: 2008

Website: http://www.newronika.com/

LinkedIn: https://www.linkedin.com/company/newronika/

Twitter: https://twitter.com/newronika

Instagram:

Facebook: https://www.facebook.com/newronikaspa